Department of Ophthalmology, UPMC Vision Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Grupo de Investigación Visión y Salud Ocular, Servicio de Oftalmología, Universidad del Valle, Cali, Colombia.
PLoS One. 2024 Jul 12;19(7):e0305586. doi: 10.1371/journal.pone.0305586. eCollection 2024.
Diabetic Retinopathy stands as a leading cause of irreversible blindness, necessitating frequent examinations, especially in the early stages where effective treatments are available. However, current examination rates vary widely, ranging from 25-60%. This study scrutinizes the Point-of-Care Diabetic Retinopathy Examination Program at the University of Pittsburgh/UPMC, delving into its composition, evolution, challenges, solutions, and improvement opportunities. Employing a narrative approach, insights are gathered from key stakeholders, including ophthalmologists and staff from primary care clinics. A quantitative analysis from 2008 to 2020 provides a comprehensive overview of program outcomes, covering 94 primary care offices with 51 retinal cameras. Program components feature automated non-mydriatic 45° retinal cameras, a dedicated coordinator, rigorous training, and standardized workflows. Over this period, the program conducted 21,960 exams in 16,458 unique individuals, revealing a diverse population with an average age of 58.5 and a balanced gender distribution. Average body mass index (33.96±8.02 kg/m2) and hemoglobin A1c (7.58%±1.88%) surpassed normal ranges, indicating prevalent risk factors for diabetes-related complications. Notably, 24.2% of patients underwent more than one exam, emphasizing program engagement. Findings indicated that 86.3% of exams were gradable, with 59.0% within normal limits, 12.1% showing some evidence of diabetic retinopathy, and 6.4% exhibiting vision-threatening diabetic retinopathy. Follow-up appointments with ophthalmologists were recommended in 31.5% of exams due to indeterminate results, positive diabetic retinopathy (≥moderate or macular exudate), or other findings like age-related macular degeneration or suspected glaucoma. The program demonstrated high reproducibility across diverse healthcare settings, featuring a sustainable model with minimal camera downtime, standardized workflows, and financial support from grants, health systems, and clinical revenues. Despite COVID-19 pandemic challenges, this research emphasizes the program's reproducibility, user-friendly evolution, and promising outcomes. Beyond technical contributions, it highlights human factors influencing program success. Future research could explore adherence to follow-up ophthalmological recommendations and its associated factors.
糖尿病视网膜病变是导致不可逆性失明的主要原因,因此需要进行频繁的检查,特别是在早期阶段,此时有有效的治疗方法。然而,目前的检查率差异很大,范围在 25-60%之间。本研究深入探讨了匹兹堡大学/UPMC 的即时护理糖尿病视网膜病变检查计划,研究了该计划的组成、演变、挑战、解决方案和改进机会。本研究采用叙述性方法,从包括眼科医生和初级保健诊所工作人员在内的主要利益相关者那里收集了相关见解。2008 年至 2020 年的定量分析提供了该计划成果的全面概述,涵盖了 94 个初级保健办公室和 51 个视网膜相机。该计划的组成部分包括自动化的非散瞳 45°视网膜相机、专门的协调员、严格的培训和标准化的工作流程。在此期间,该计划对 16458 名个体中的 21960 人进行了检查,发现这是一个具有不同特征的人群,平均年龄为 58.5 岁,性别分布均衡。平均体重指数(33.96±8.02kg/m2)和糖化血红蛋白(7.58%±1.88%)超过正常范围,表明存在糖尿病相关并发症的常见风险因素。值得注意的是,有 24.2%的患者接受了不止一次检查,这表明他们对该计划的参与度很高。研究结果表明,86.3%的检查结果是可分级的,其中 59.0%处于正常范围内,12.1%显示出一些糖尿病视网膜病变的证据,6.4%显示出威胁视力的糖尿病视网膜病变。由于不确定结果、阳性糖尿病视网膜病变(≥中度或黄斑渗出)或其他发现,如年龄相关性黄斑变性或疑似青光眼,有 31.5%的检查需要预约眼科医生进行随访。该计划在各种医疗保健环境中具有高度的可重复性,具有可持续的模式,相机停机时间短,工作流程标准化,并且得到赠款、医疗系统和临床收入的财政支持。尽管受到 COVID-19 大流行的挑战,但这项研究强调了该计划的可重复性、用户友好的演变和良好的结果。除了技术贡献外,它还强调了影响计划成功的人为因素。未来的研究可以探索对眼科随访建议的依从性及其相关因素。